Sitemap

December 10, 2009 Articles

Filter by Available Specialty
  1. AAO report: DSEK and PK have similar risks, graft survival and visual acuity
  2. ACCORD 12/0405 Prodige 2: Radiation dose intensification with capecitabine/oxaliplatin may be optimal for rectal adenocarcinoma
  3. Adjuvant radiotherapy decreased risk for lymph node cancer recurrence in high-risk melanoma
  4. Alcohol consumption increased risk for breast cancer recurrence by 34%
  5. Allogeneic hematopoietic stem-cell transplant protocol successful in adult sickle cell disease
  6. ATA revised guidelines for thyroid nodules, differentiated thyroid cancer
  7. Bone marrow aspirate may offer an alternative to THR in patients with avascular necrosis
  8. Cataract surgery most successful at reducing IOP in POAG, PACG cases with high preop IOP
  9. CHAMPION PLATFORM: Cangrelor not superior to placebo for reduction of combined study endpoint
  10. Combination of heart rate recovery, T-wave alternans associated with improved risk assessment
  11. Combined triamcinolone acetonide-PDT may reduce number of re-treatments
  12. Concurrent CRT no better than neoadjuvant chemotherapy for nasopharyngeal carcinoma
  13. Corneal ring segments decrease corneal curvature but do not affect biomechanics
  14. Denosumab reduced breast cancer skeletal-related events further than zoledronic acid
  15. Dose-painted intensity-modulated radiation therapy reduced toxicity for anal canal cancer
  16. Educate patients and families for the end of life
  17. Epimacular radiation and anti-VEGF therapy may help fill current treatment gaps
  18. FDA Anti-Infective Drug Advisory Committee recommends aztreonam for treatment of P. aeruginosa in patients with cystic fibrosis
  19. FDA Anti-Infective Drug Advisory Committee recommends aztreonam for treatment of P. aeruginosa in patients with cystic fibrosis
  20. Femtosecond laser enables safe, reproducible cataract surgery
  21. Following key surgical guidelines helps executing arthroscopic PCL reconstruction
  22. Functional, anatomical success rates for dacryocystorhinostomy differ between specialists, trainees
  23. Gene therapy for glaucoma could have potential
  24. Group purchasing reduces annual health care costs by more than $36 billion
  25. GU, GI toxicity due to proton therapy minimal for prostate cancer
  26. Hypervitaminosis D
  27. Initial radiotherapy, chemotherapy produced equivalent results with anaplastic glioma
  28. Intrastromal corneal ring segment improves visual acuity, corneal stability at 5 years
  29. Is there an optimal target for disparities research?
  30. Ocular surface disease needs to be managed before and after surgery
  31. Oncology gift guide
  32. Optimizing the ocular surface before surgery may reduce dry eye postop
  33. Patient referred for evaluation of a white lesion in the inferior fornix
  34. PCI reduced risk for developing brain metastases, increased memory loss in NSCLC
  35. Physician describes characteristics of white-dot chorioretinal inflammatory syndromes
  36. Practice pearls for providing leadership through teaching
  37. Recognizing gemcitabine-induced thrombotic thrombocytopenic purpura
  38. Results from a highly preliminary ophthalmologist study reveal signposts for career, life happiness
  39. Role of KRAS/BRAF in metastatic colorectal cancer still emerging
  40. Should LRIs or additional procedures that may harm the corneal surface be avoided in cataract patients with pre-existing dry eye?
  41. Stromal demarcation line visible after corneal cross-linking with anterior segment OCT
  42. The right target: how survival is affected by race/ethnicity, socioeconomic status
  43. The right tools can make cataract surgery more efficient
  44. The utility of PET/CT in monitoring treatment response and detecting unusual metastases in esophageal cancer
  45. Tumor volumes derived from PET/CT smaller than those derived from CT alone
  46. Varicella vaccine may also reduce herpes zoster incidence in children
  47. Varicella vaccine may also reduce herpes zoster incidence in children
  48. VTE did not affect survival in lenalidomide/ dexamethasone-treated multiple myeloma